Bladder cancer: open trials in Japan

28 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT05614739
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center Hospital East, Chiba · Aichi Cancer Center Hospital, Nagoya · National Cancer Center Hospital, Tokyo · Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center Hospital, Chūōku · National Cancer Center Hospital East, Kashiwa, Chiba · The Cancer Institute Hospital of JFCR, Kōtō City · Aichi Cancer Center Hospital, Nagoya
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East (NCCHE) - Kashiwa Campus, Kashiwa · The Cancer Institute Hospital of JFCR, Koto-ku · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Sakai · Hokkaido University Hospital, Sapporo
Registry updated 2026-11-04
NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hyogo Prefectural Amagasaki General Medical Center, Amagasaki · St. Marianna University Hospital, Kawasaki · Kobe City Medical Center General Hospital, Kobe · National Hospital Organization Kumamoto Medical Center, Kumamoto · Osaka International Cancer Institute, Osaka · Gunma Prefectural Cancer Center, Ōta-ku · Saitama Medical Center, Saitama · JRC Wakayama Medical Center, Wakayama · Yokohama City University Medical Center, Yokohama · Yokohama Municipal Citizen's Hospital, Yokohama · Yokosuka Kyosai Hospital, Yokosuka
Registry updated 2026-11-03
NCT06919965
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Juntendo University Hospital, Bunkyō City · Funabashi Municipal Medical Center, Funabashi · Hakodate Goryoukaku Hospital, Hakodate · St. Marianna University Hospital, Kawasaki · The Jikei University Hospital, Minatoku · Toho University Sakura Medical Center, Sakura · Yokohama City University Medical Center, Yokohama · Yokohama Municipal Citizen's Hospital, Yokohama
Registry updated 2026-11-03
NCT07416123
A Study of GEN1106 in Participants With Solid Tumors
Trial Treatment · Phase 1 · Genmab
National Cancer Center Hospital, Chuo Ku
Registry updated 2026-11-03
NCT07419295
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Institute of Science Tokyo Hospital ( Site 0421), Bunkyo · Kyushu University Hospital ( Site 0434), Fukuoka · Gifu University Hospital ( Site 0427), Gifu · Hirosaki University Hospital ( Site 0435), Hirosaki · Nara Medical University Hospital ( Site 0423), Kashihara · St. Marianna University Hospital ( Site 0422), Kawasaki · Kagawa University Hospital ( Site 0424), Kita-gun · Kobe University Hospital ( Site 0431), Kobe · Cancer Institute Hospital of JFCR ( Site 0426), Koto · Kyoto University Hospital ( Site 0433), Kyoto · Nagoya University Hospital ( Site 0429), Nagoya · Kitasato University Hospital ( Site 0425), Sagamihara · Osaka Rosai Hospital ( Site 0428), Sakai · Hokkaido University Hospital ( Site 0436), Sapporo · Ehime University Hospital ( Site 0430), Tōon · University of Tsukuba Hospital ( Site 0432), Tsukuba
Registry updated 2026-11-03
NCT07660055
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Kashiwa
Registry updated 2026-11-03
NCT07475806
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Trial Treatment · Phase 2 · Astellas Pharma Global Development, Inc.
Institute of Science Tokyo Hospital, Bunkyo-ku · Tokyo Metropolitan Hospital Organization-Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku · Gifu University Hospital, Gifu · St. Marianna University Hospital, Kawasaki · Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe · The Cancer Institute Hospital-Japanese Foundation for Cancer, Koto-ku · Kyoto University Hospital, Kyoto · Osaka Metropolitan University Hospital, Osaka · University of Tsukuba Hospital, Tsukuba · Yamaguchi University Hospital - Center For Clinical Research, Ube
Registry updated 2026-11-02
NCT06510374
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Trial Treatment · Phase 3 · Ferring Pharmaceuticals
Institute of Science Tokyo Hospital, Bunkyo-ku · Kyushu University Hospital, Fukuoka · Hiroshima University Hospital, Hiroshima · Hitachi General Hospital, Hitachi · Nara Medical University Hospital, Kashihara · St. Marianna University Hospital, Kawasaki · Kobe University Hospital, Kobe · National Hospital Organization Shikoku Cancer Center, Matsuyama · Aichi Medical University Hospital, Nagakute · Nagoya University Hospital, Nagoya · Kochi Medical School Hospital, Nankoku · Japanese Red Cross Narita Hospital, Narita · The University of Tokyo Hospital, Tokyo · Mie University Hospital, Tsu · University of Tsukuba Hospital, Tsukuba · Wakayama Medical University Hospital, Wakayama · Yokohama City University Hospital, Yokohama
Registry updated 2026-10-30
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Saitama Medical University International Medical Center, Hidaka · HAKUAIKAI Social Medical Corporation Sagara Hospital, Kagoshima · Kanagawa Cancer Center, Kanagawa · National Cancer Center Hospital East, Kashiwa-shi · NHO Shikoku Cancer Center, Matsuyama · Shizuoka Cancer Center, Nagaizumi-chō · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Osakasayama-Shi · Saitama Cancer Center, Saitama · National Cancer Center Hospital, Tokyo · Showa Medical University Hospital, Tokyo · Cancer Institute Hospital of JFCR, Tokyo · Yokohama City University Medical Center, Yokohama
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East, Kashiwa · The Cancer Institute Hospital of JFCR, Koto-ku · National Hospital Organization Shikoku Cancer Center, Matsuyama · Shizuoka Cancer Center, Nagaizumi-chō · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Ōsaka-sayama · Saitama Cancer Center, Saitama
Registry updated 2026-10-26
NCT07287995
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Trial Treatment · Phase 1/2 · Astellas Pharma Global Development, Inc.
National Cancer Center Hospital, Chuo Ku · Kansai Medical University Hospital, Hirakata-shi · National Cancer Center Hospital East, Kashiwa-shi · The Cancer Institute Hospital of JFCR, Koto-ku
Registry updated 2026-10-22
NCT07421700
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Trial Treatment · Phase 1/2 · Pfizer
National Hospital Organization Kyushu Cancer Center, Fukuoka · Keio University Hospital, Shinjuku-ku · Yamagata University Hospital, Yamagata
Registry updated 2026-10-08
NCT07218380
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Trial Treatment · Phase 3 · Eli Lilly and Company
National Cancer Center Hospital, Chūōku · Kyushu University Hospital, Fukuoka · Hirosaki University Hospital, Hirosaki · Kanazawa University Hospital, Kanazawa · National Cancer Center Hospital East, Kashiwa · St. Marianna University Hospital, Kawasaki · Kagawa University Hospital, Kita-ku · Kobe City Medical Center General Hospital, Kobe · The Cancer Institute Hospital of JFCR, Kōtoku · Kyoto University Hospital, Kyoto · National Hospital Organization Shikoku Cancer Center, Matsuyama · Aichi Cancer Center Hospital, Nagoya · Niigata University Medical & Dental Hospital, Niigata · Osaka International Cancer Institute, Osaka · Gunma Prefectural Cancer Center, Otashi · Hokkaido University Hospital, Sapporo · Tohoku University Hospital, Sendai · Iwate Medical University Hospital, Shiwa-gun Yahaba-cho · Tokushima University Hospital, Tokushima · Tsukuba University Hospital, Tsukuba
Registry updated 2026-10-07
NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Trial Treatment · Phase 2 · Protara Therapeutics
Hyogo Prefectural Amagasaki General Medical Center, Amagasaki-shi · Toho University Medical Center Sakura Hospital, Fuji-shi · Kyushu University Hospital, Fukuoka · Funabashi Municipal Medical Center, Funabashi-shi · Hitachi General Hospital, Hitachi-shi · Komaki City Hospital, Komaki-shi · Japanese Red Cross Aichi Medical Center Nayoya Daiichi, Nagoya · Niigata Cancer Center Hospital, Niigata · Japanese Red Cross Osaka Hospital, Osaka · Fuji City General Hospital, Sakura-shi · Toyama University Hospital, Toyama · Yokohama Municipal Citizen's Hospital, Yokohama
Registry updated 2026-08-24
NCT07129993
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Trial Treatment · Phase 2/3 · Daiichi Sankyo
Bunkyō City · Fukuoka · Hirosaki-shi · Kanazawa · Kawasaki · Kōtoku · Kumamoto · Kyoto · Nagoya · Niigata · Okayama · Osaka · Osakasayama-shi · Sapporo · Shinjuku-ku · Toyama · Tsukuba · Ube-shi
Registry updated 2026-08-20
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
National Cancer Center Hospital East, Kashiwa
Registry updated 2026-08-17
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Bunkyo-ku · Kawasaki · Koto-ku · Toyoma
Registry updated 2026-07-29
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Trial Treatment · Phase 2 · Seagen, a wholly owned subsidiary of Pfizer
National Cancer Center Hospital East, Kashiwa-shi · The Cancer Institute Hospital of JFCR, Koto-ku · Osaka Prefectural Hospital Organization - Osaka International Cancer Institute, Osaka · Sapporo Medical University Hospital, Sapporo · Osaka University Hospital, Suita-shi · Tokushima University Hospital, Tokushima
Registry updated 2026-07-22
NCT07720284
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Trial Treatment · Phase 3 · AstraZeneca
Fukuoka · Hamamatsu · Hirosaki-shi · Kanazawa · Kashihara-shi · Kawasaki-shi · Kita-gun · Kobe · Kōtoku · Kumamoto · Nagasaki · Nagoya · Osaka · Toyama · Tsukuba
Registry updated 2026-07-22
NCT04564781
Predicting BCG Response
Research · Cedars-Sinai Medical Center
Kyoto University, Kyoto
Registry updated 2026-07-06
NCT03193515
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
Research · Cedars-Sinai Medical Center
Kyoto University Graduate School of Medicine, Kyoto
Registry updated 2026-02-04
NCT03193541
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Research · Cedars-Sinai Medical Center
Nara Prefecture Seiwa Medical Center, Nara · Nara Medical University, Nara
Registry updated 2026-02-04
NCT06943521
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Tanabe Pharma America, Inc.
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East, City
Registry updated 2025-12-11

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error